IP Peru, Bioavailability of Iron From Potatoes

NCT04216030 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-05-13

No results posted yet for this study

Summary

To combat iron deficiency in Low and Middle-Income Countries, sustainable food-based solutions have to be implemented to serve populations, not only individuals. One solution is the introduction of iron biofortified staple crops on market level. Before market level introduction, the bioavailability of iron in the new biofortified Irish Potato (IP) breed needs to be assessed. In this study the investigator compares the fractional and total iron absorption after extrinsic stable isotope labelling of the new biofortified high iron IP variety and a normal market level IP variety. The study is conducted in Peruvian women of reproductive age with marginal iron status.

Conditions

Interventions

OTHER

High Fe IP meal labelled with Fe-58

500 gram steamed, mashed OFSP high Fe with 0.33 mg FeSO4-58 daily for 10 days

OTHER

Control OFSP meal labelled with Fe-57

500 gram steamed, mashed OFSP control with 0.33 mg FeSO5-57 daily for 10 days

Sponsors & Collaborators

  • Genetics, Genomics and Crop Improvement Program, International Potato Center, Lima, Peru

    collaborator UNKNOWN
  • United States Agency for International Development (USAID)

    collaborator FED
  • Quadram Institute Bioscience

    collaborator OTHER
  • Instituto de Investigacion Nutricional, Lima, Peru

    collaborator UNKNOWN
  • Swiss Federal Institute of Technology

    lead OTHER

Principal Investigators

  • Reyna Liria · INN

  • Mary Penny · INN

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-14
Primary Completion
2019-08-08
Completion
2019-08-08

Countries

  • Peru

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04216030 on ClinicalTrials.gov